AOD 9604 does not interact with growth hormone receptors, does not affect insulin signaling, and does not cross into the central nervous system to alter appetite or mood
Purchase AOD-9604 from Regen Labs
The strongest published finding is from the foundational Biochemical Pharmacology study by Neelakantan et al.: in diet-induced obese mice, daily 5-Amino-1MQ administration produced reductions in body weight, white adipose tissue mass, and adipocyte size without any significant change in food intake
At Soza Clinic, we often recommend prophylactic B12 therapy beginning in early fall for patients with histories of seasonal mood changes
Until such a study exists, claims of route superiority in either direction are extrapolation, not data
This is the practical reason a reader who is nervous about small-volume accuracy might prefer the 50 mg protocol the trade-off being that each vial carries fewer total doses, as the supply math shows next